Hyperfine Unveils NEURO PMR Study Results Showing High Diagnostic Value for Portable MRI in Neurology Clinics

Reuters

Jan 20

<a href="https://laohu8.com/S/HYPR">Hyperfine</a> Unveils NEURO PMR Study Results Showing High Diagnostic Value for Portable MRI in Neurology Clinics

Hyperfine Inc. has announced results from the NEURO PMR study, which were presented at the American Society of Neuroimaging Annual Meeting in San Juan, Puerto Rico, on January 16, 2026. The study evaluated the clinical utility and patient experience of the portable Swoop® system, an FDA-cleared AI-powered portable MRI for brain imaging, compared to standard-of-care MRI in outpatient neurology clinics. The prospective, multi-center study enrolled 125 patients across DENT Neurologic Institute and Texas Neurology, including individuals with headache, dementia, multiple sclerosis follow-up, and tumor surveillance. Patients underwent brain imaging with both the Swoop® system and conventional high-field MRI, allowing for direct comparison between the modalities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hyperfine Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260120756787) on January 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2604511559"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2604511559\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2604511559?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-20 21:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604511559","market":"us","top_or_hot":-1,"title":"Hyperfine Unveils NEURO PMR Study Results Showing High Diagnostic Value for Portable MRI in Neurology Clinics","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/HYPR\">Hyperfine</a> Unveils NEURO PMR Study Results Showing High Diagnostic Value for Portable MRI in Neurology Clinics\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Hyperfine Inc. has announced results from the NEURO PMR study, which were presented at the American Society of Neuroimaging Annual Meeting in San Juan, Puerto Rico, on January 16, 2026. The study evaluated the clinical utility and patient experience of the portable Swoop® system, an FDA-cleared AI-powered portable MRI for brain imaging, compared to standard-of-care MRI in outpatient neurology clinics. The prospective, multi-center study enrolled 125 patients across DENT Neurologic Institute and Texas Neurology, including individuals with headache, dementia, multiple sclerosis follow-up, and tumor surveillance. Patients underwent brain imaging with both the Swoop® system and conventional high-field MRI, allowing for direct comparison between the modalities.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hyperfine Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260120756787) on January 20, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hyperfine Unveils NEURO PMR Study Results Showing High Diagnostic Value for Portable MRI in Neurology Clinics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHyperfine Unveils NEURO PMR Study Results Showing High Diagnostic Value for Portable MRI in Neurology Clinics\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-20 21:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/HYPR\">Hyperfine</a> Unveils NEURO PMR Study Results Showing High Diagnostic Value for Portable MRI in Neurology Clinics\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Hyperfine Inc. has announced results from the NEURO PMR study, which were presented at the American Society of Neuroimaging Annual Meeting in San Juan, Puerto Rico, on January 16, 2026. The study evaluated the clinical utility and patient experience of the portable Swoop® system, an FDA-cleared AI-powered portable MRI for brain imaging, compared to standard-of-care MRI in outpatient neurology clinics. The prospective, multi-center study enrolled 125 patients across DENT Neurologic Institute and Texas Neurology, including individuals with headache, dementia, multiple sclerosis follow-up, and tumor surveillance. Patients underwent brain imaging with both the Swoop® system and conventional high-field MRI, allowing for direct comparison between the modalities.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hyperfine Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260120756787) on January 20, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HYPR","symbol_name":"Hyperfine","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDLnNhs5:1","article_id":"2604511559","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2604511559","pubTimestamp":1768914915,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Hyperfine Inc. has announced results from the NEURO PMR study, which were presented at the American Society of Neuroimaging Annual Meeting in San Juan, Puerto Rico, on January 16, 2026. The study evaluated the clinical utility and patient experience of the portable Swoop system, an FDA-cleared AI-powered portable MRI for brain imaging, compared to standard-of-care MRI in outpatient neurology clinics. The prospective, multi-center study enrolled 125 patients across DENT Neurologic Institute and Texas Neurology, including individuals with headache, dementia, multiple sclerosis follow-up, and tumor surveillance. Patients underwent brain imaging with both the Swoop system and conventional high-field MRI, allowing for direct comparison between the modalities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and sh","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HYPR":"Hyperfine","BK4082":"医疗保健设备"},"translate_title":"Hyperfine公布NEURO PMR研究结果显示便携式MRI在神经病学诊所中的高诊断价值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HYPR":0.9},"content_text":"Hyperfine Unveils NEURO PMR Study Results Showing High Diagnostic Value for Portable MRI in Neurology Clinics\n    \n\n        Hyperfine Inc. has announced results from the NEURO PMR study, which were presented at the American Society of Neuroimaging Annual Meeting in San Juan, Puerto Rico, on January 16, 2026. The study evaluated the clinical utility and patient experience of the portable Swoop® system, an FDA-cleared AI-powered portable MRI for brain imaging, compared to standard-of-care MRI in outpatient neurology clinics. The prospective, multi-center study enrolled 125 patients across DENT Neurologic Institute and Texas Neurology, including individuals with headache, dementia, multiple sclerosis follow-up, and tumor surveillance. Patients underwent brain imaging with both the Swoop® system and conventional high-field MRI, allowing for direct comparison between the modalities.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hyperfine Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260120756787) on January 20, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}